Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -6.25
- Piotroski Score 2.00
- Grade Buy
- Symbol (PPBT)
- Company Purple Biotech Ltd.
- Price $2.19
- Changes Percentage (-13.78%)
- Change -$0.35
- Day Low $2.00
- Day High $2.65
- Year High $23.20
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.79
- Trailing P/E Ratio -0.72
- Forward P/E Ratio -0.72
- P/E Growth -0.72
- Net Income $-19,880,000
Income Statement
Quarterly
Annual
Latest News of PPBT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Purple Biotech Ltd (PPBT) Stock Price, News, Quote & History
Get ready for upcoming stock splits happening from September 16 to September 20. A stock split increases outstanding shares, lowering stock prices while keeping market capitalization constant. Convers...
By Yahoo! Finance | 2 months ago
